A dual-approach strategy to optimize the safety and efficacy of pharmacopuncture
강사명Hyojung Kim
강의시간20분
강의개설일2025-12-09
강의소개
Acupuncture has been widely used as alternative and complementary medicine for pain relief in and around
East Asia about 2,000 years. Among various acupuncture techniques being newly developed, pharmacopuncture is a
relatively novel acupuncture technique.
While the conventional acupuncture treatment incorporates the physical stimulation of associated meridians and
acupoints, pharmacopuncture is a form of acupuncture treatment which combines with injection of herbal medicine
or animal product at the acupuncture points. The advantages of pharmacopuncture treatment are more rapid effects,
synergistic effects, and the easy for controlling dosage compared to acupuncture treatment. Numerous types of
pharmacopuncture are applied to treat diverse disorders; especially, it is frequently used to reduce an inflammatory
response, thereby relieving the pain.
Recently, it has been reported that medicinal materials used for pharmacopuncture treatment are prepared and applied
by various methods of the operator at discretion, which has higher risks of adverse events than other treatments. In
consideration of these problems, it is required to standardize the raw materials and the manufacturing process to
provide safe, stable, and effective pharmacopuncture by enriching the effective components and removing the harmful
factors. In vitro and in vivo as well as clinical trials have showed that bee venom(BV) may be an important source of
pharmacopuncture to cure diverse diseases such as arthritis and rheumatism, pain, and cancer. Since BV contains
several active ingredients with a wide variety of pharmaceutical properties, the identification of a single constituent, the
possible mechanisms, and a standardization of the applicable route and formulation are needed. Our present results
may be helpful to set priorities and directions for development of pharmacopuncture to target the clinical application.
강사소개
Education
Oct 2001 – Dec. 2004 Ludwig-Maximilians-Universitaet Muenchen, Germany, Ph.D.(Human Biology)
Mar. 1999 – Feb. 2001 Kyungpook National University, Korea , M.A.(Animal Science and Biotechnology)
Work experience
Jul 2015 – present
Dec 2012 – Jun 2015
Apr 2011 – Nov 2012
Jul 2006 – Feb 2011
Dec 2004 – Aug 2005
National Institute for Korean Medicine Development (Senior Researcher)
Chubu University, Japan (Assistant Professor)
Kyungpook National University, Korea (Contract Professor)
Kyungpook National University, Korea (Postdoctoral researcher)
Dong-A University, Korea (Postdoctoral Researcher)